About Genoplan
Genoplan is a company based in New York (United States) founded in 2014. Genoplan has raised $17.25 million across 4 funding rounds from investors including GC Genome, GC Holdings and PIA Investment Management. Genoplan operates in a competitive market with competitors including 23andMe, Color, Veritas Genetics, InformedDNA and Arivale, among others.
- Headquarter New York, United States
- SectorsHealthcare
- Website genoplan.com/en-int
- Social Facebook
- Total Equity Funding$17.25M (USD)
in 4 rounds
- Latest Funding Round$13M (USD), Series B
Sep 2018
- InvestorsGC Genome
& 7 more
Funding Insights of Genoplan
Genoplan has successfully raised a total of $17.25M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $13 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.25M
- Total Rounds 4
- Last Round Series B β $13M
- First Round $45,000
(Mar 2015)
- Investors Count 8
All 4 funding rounds of Genoplan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | $13M | Series B | β | GC Holdings | |
| Mar 2016 | $4.2M | Series A | β | β | |
| Jun 2015 | – | Seed | β | SparkLabs | β |
| Mar 2015 | $45,000 | Seed | β | β | β |
8 investors in total: 8 institutional.
Investors in Genoplan
Genoplan has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include GC Genome, GC Holdings and PIA Investment Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | piagp.com | - | |
Dayli Partners is focused on bio-healthcare and fintech investments. | – | dayli.partners | Seoul, South Korea | |
Investments are directed toward semiconductors, telecommunications, software, and medical sectors. | – | samsungventures.com | Seoul, South Korea | |
Early-stage venture capital arm of SoftBank Group | – | sbvacorp.com | Seoul, South Korea | |
Startup growth is accelerated through focused accelerator programs by SparkLabs. | – | sparklabs.co.kr | Seoul, South Korea | |
Integrated optic platforms and polymers are developed and manufactured. | 2002 | gc-holdings.com | Fremont, United States | |
Developer of genomic diagnostic tests for multiple diseases | 2013 | gc-genome.com | - | |
- | – | wonik.co.kr | - |
Investor details for Genoplan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genoplan
8 people are tracked at Genoplan (2 in leadership, 5 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Brian Byungkyu Kang | Founder & CEO | Leadership |
Byung-Chul Lee | Chief Scientific Officer | Head of RnD Division | Leadership |
Byungjoon Choi | Advisor | Board & advisors |
Jaewoo Moon | Advisor | Board & advisors |
Honghui Won | Advisor | Board & advisors |
Hie Lim Kim | Advisor | Board & advisors |
Jungmin Kim | Advisor | Board & advisors |
Mary KIM | HR Manager | Team |
Complete people profiles for Genoplan
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genoplan
3 dated milestones of Genoplan across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Genoplan is founded.
- Funding First funding round of $45K.
- Funding Latest funding round, Series B, of $13.0M.
Competitors of Genoplan
Genoplan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 23andMe, Color, Veritas Genetics, InformedDNA and Arivale, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 23andme.com | 2006 | Sunnyvale, United States | $943.53M | 755 | Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | |
| color.com | 2013 | Burlingame, United States | $506.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| veritasgenetics.com | 2014 | Danvers, United States | $53.38M | 14 | Genetic testing products for health risks and traits are offered. | |
| informeddna.com | 2007 | St Petersburg, United States | $19.22M | – | Network of genetics experts provided to assist patients and providers. | |
| arivale.com | 2014 | Seattle, United States | $49.6M | – | Provider of direct-to-consumer genetic testing. | |
| myome.com | 2017 | San Carlos, United States | $23M | – | Provider of a platform for gene analysis to determine genetic diseases and drug response | |
| gbhealthwatch.com | 2012 | San Diego, United States | $9.78M | – | Personalized nutrition plans are offered via an online health platform. | |
| pwnhealth.com | 2015 | New York, United States | – | – | Population health and clinical genomic screening solutions are provided. | |
| selfdecode.com | 2016 | San Luis Obispo, United States | $8M | 4 | Personal genome data is analyzed for health and wellness reports. |
Detailed competitors of Genoplan
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genoplan
The website of Genoplan (genoplan.com) receives about 98.7K visits a month.
- Monthly visits98.7K
▲ 188.1% vs previous month
Websites whose visitors overlap most with Genoplan. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details | |
shop.dr-gene.jp | shop.dr-gene.jp | 54% | – | #1,868,508 | β |
illuminakk.co.jp | illuminakk.co.jp | 51% | – | #10,034,310 | β |
genelife.jp | genelife.jp | 50% | – | #274,837 | β |
genex.co.jp | genex.co.jp | 45% | – | #4,019,656 | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 6 similar websites and full traffic analytics for Genoplan
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Genoplan
Complete news archive for Genoplan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Genoplan
10 companies that operate in the same segment as Genoplan (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genoplan
Genoplan was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Genoplan is headquartered in New York, United States. It is registered at New York, New York, United States.
Genoplan is a funded company, having raised a total of $17.25M across 4 funding rounds to date. The company's 1st funding round was a Seed of $45K, raised on Mar 2015.
Genoplan was founded in 2014 and is based in New York, United States. Operations focus on the genetic testing sector, where saliva samples are collected and analyzed for DNA-based health insights. Tailored lifestyle recommendations are generated, covering areas such as diet, health foods, workouts, and cosmetics, to support individual wellness decisions.
Genoplan's top competitors include 23andMe, Veritas Genetics and Color.
Genoplan has 8 investors. Key investors include GC Genome, GC Holdings, PIA Investment Management, Dayli Partners, and Wonik.